Detail page

Knowledge Web

Person

Christian Labenz (1989-)

Internist

Name	Christian Labenz
Time	1989- (Date of birth and death)
Place	Essen (Geburtsort) Deutschland
Gender	männlich
Academic degree	PD (Habilitationsschrift am Fachbereich Universitätsmedizin der Johannes Gutenberg-Universität Mainz) (2020) Dr. med. (Univ. Duisburg-Essen) (2016)
Profession	Internist (characteristic profession)
Related	Universitätsmedizin Mainz
Further information	Habil. Fach Innere Medizin an der Univ. Mainz
Source	Vorlage
Record type	Person
GND-Identifier	1104153602
Record ID	1104153602
Involved in show all MCAM is a prognostic biomarker in patients with liver cirrhosis and HCC Costs of a structured early detection program for advanced liver fibrosis and cirrhosis: insights on the “plus” of Check-up 35+ How do (false) positively screened patients experience a screening programme for liver cirrhosis or fibrosis in Germany? A qualitative study Markers of cell death predict therapy response in patients with cirrhosis and hepatorenal syndrome Bevacizumab in combination with octreotide rescues a patient with liver cirrhosis, GAVE syndrome and refractory hemorrhage – a case report Diabetes mellitus – risk factor and potential future target for hepatic encephalopathy in patients with liver cirrhosis? Prescription rates of common medications in patients with decompensated cirrhosis in Germany Burden of depression and anxiety disorders per disease codes in patients with lymphoma in Germany Burden of depression and anxiety disorders per disease codes in patients with lymphoma in Germany Hepatische Enzephalopathie - Epidemiologie, Diagnostik und klinische Relevanz Hepatische Enzephalopathie Die Rolle des Fettsäuretransportproteins CD36/FAT in Bezug auf die Progression des Hepatozellulären Karznioms auf Grundlage einer nicht-alkoholischen Fettlebererkrankung

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Christian Labenz (1989-)

MCAM is a prognostic biomarker in patients with liver cirrhosis and HCC

Costs of a structured early detection program for advanced liver fibrosis and cirrhosis: insights on the “plus” of Check-up 35+

How do (false) positively screened patients experience a screening programme for liver cirrhosis or fibrosis in Germany? A qualitative study

Markers of cell death predict therapy response in patients with cirrhosis and hepatorenal syndrome

Bevacizumab in combination with octreotide rescues a patient with liver cirrhosis, GAVE syndrome and refractory hemorrhage – a case report

Diabetes mellitus – risk factor and potential future target for hepatic encephalopathy in patients with liver cirrhosis?

Prescription rates of common medications in patients with decompensated cirrhosis in Germany

Burden of depression and anxiety disorders per disease codes in patients with lymphoma in Germany

Burden of depression and anxiety disorders per disease codes in patients with lymphoma in Germany

Hepatische Enzephalopathie - Epidemiologie, Diagnostik und klinische Relevanz

Hepatische Enzephalopathie

Die Rolle des Fettsäuretransportproteins CD36/FAT in Bezug auf die Progression des Hepatozellulären Karznioms auf Grundlage einer nicht-alkoholischen Fettlebererkrankung